{"id":"W4415877993","doi":"10.51731/cjht.2025.1281","title":"Ibrutinib","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Ibrutinib; Reimbursement; Cancer; Antineoplastic Drugs; Cancer drugs; Drug","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001459128,0.0003271152,0.0003952367,0.0009734649,0.0002859563,0.0009646556,0.0004739467,0.0006102351,0.009801349],"category_scores_gemma":[0.002418628,0.0001035186,0.000602786,0.0009109952,0.0001878392,0.000430803,0.0003496209,0.0008924433,0.002327111],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002018697,"about_ca_system_score_gemma":0.002177817,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005284687,"about_ca_topic_score_gemma":0.01446382,"domain_scores_codex":[0.9991629,0.0002743078,0.0001034624,0.00006924642,0.0002940191,0.00009606215],"domain_scores_gemma":[0.9993316,0.0001865118,0.0001883385,0.00002128541,0.0002114967,0.00006080612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006873574,0.00004877533,0.0007800763,0.003282263,0.0001814201,0.0002215843,0.00004797098,0.0003122224,0.001987603,0.005693255,0.07147822,0.9152792],"study_design_scores_gemma":[0.000252439,0.0001872468,0.002142472,0.002366435,0.0002154283,0.0008367061,0.00003538249,0.0001151154,0.001149547,0.0009443493,0.9917421,0.00001281486],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.008003095,0.854461,0.002143956,0.01159322,0.00152474,0.0002148915,0.00166044,0.0001947393,0.120204],"genre_scores_gemma":[0.1947325,0.7168434,0.01013967,0.01180396,0.001757436,0.0003075433,0.003826783,0.00007569576,0.06051305],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.009801349,"threshold_uncertainty_score":0,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02848752115301347,"score_gpt":0.3536033925155721,"score_spread":0.3251158713625587,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}